WOLFENBUETTEL, Germany--(BUSINESS WIRE)--BIOBASE announced today the signing of the BRENDA-AMENDA license agreement with the Bayer subgroup Bayer HealthCare. This license provides researchers at the Bayer HealthCare Institute for Target Research in Wuppertal, Germany with access to this expert-maintained database that summarizes more than fifty years of enzyme and metabolism research.
